Status:
COMPLETED
Autologous Stem Cells in Osteoarthritis
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
30+ years
Phase:
PHASE1
Brief Summary
Patients with osteoarthritis, a degenerative joint disease, that meet inclusion criteria will be allocated into two groups: * The control group will receive Acetaminophen 750mg orally every 8 hours *...
Eligibility Criteria
Inclusion
- Patients with knee osteoarthritis grade II or III of the Kellgren-Lawrence radiographic scale
- Age \> 30 years
Exclusion
- Neurodegenerative, autoimmune, genetic or psychiatric diseases
- Active infection
- Recent joint infection
- Knee surgery history
- Knee joint fracture history
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT01485198
Start Date
August 1 2011
End Date
May 1 2014
Last Update
March 1 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology Service
Monerrey, Nuevo León, Mexico, 64460
2
Traumatology Service
Monterrey, Nuevo León, Mexico, 64460